0000899243-22-010986.txt : 20220314 0000899243-22-010986.hdr.sgml : 20220314 20220314213315 ACCESSION NUMBER: 0000899243-22-010986 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220310 FILED AS OF DATE: 20220314 DATE AS OF CHANGE: 20220314 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dmytruk Mark E. CENTRAL INDEX KEY: 0001873507 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40097 FILM NUMBER: 22738661 MAIL ADDRESS: STREET 1: C/O SOARING EAGLE ACQUISITION CORP. STREET 2: 955 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc. CENTRAL INDEX KEY: 0001830214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 872652913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (877) 442-5362 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp. DATE OF NAME CHANGE: 20210210 FORMER COMPANY: FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp. DATE OF NAME CHANGE: 20201027 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2022-03-10 0 0001830214 Ginkgo Bioworks Holdings, Inc. DNA 0001873507 Dmytruk Mark E. C/O GINKGO BIOWORKS HOLDINGS, INC. 27 DRYDOCK AVENUE BOSTON MA 02210 0 1 0 0 See Remarks Class B Common Stock 2022-03-10 4 A 0 2617558 0.00 A Class A Common Stock 2617558 2931655 D Class B Common Stock 2022-03-10 4 F 0 289898 3.37 D Class A Common Stock 289898 2641757 D Class B Common Stock 2022-03-11 4 A 0 500000 0.00 A Class A Common Stock 500000 3181757 D Shares of the Class B Common Stock may be converted into shares of Class A Common Stock, on a one-to-one basis, at the option of the holder at any time and have no expiration date. The reporting person was previously granted awards of restricted stock units covering Class B Common Stock, which vest based upon the Issuer's achievement of an event condition (i.e., an underwritten initial public offering or a change in control), subject to additional time based vesting conditions in accordance with the terms of the award. On March 10, 2022, the Compensation Committee of the Issuer's Board of Directors, after consideration of the completion of the initial business combination, modified the event condition, resulting in the immediate vesting of 650,295 restricted stock units for which the time based vesting requirements had been satisfied as of December 31, 2021 and the issuance of a corresponding number of shares of Class B Common Stock. The remaining restricted stock units covering shares of Class B Common Stock will continue to vest in accordance with the terms of the award. Represents shares withheld by the Issuer to satisfy the reporting person's tax withholding obligations. Not a market sale. Represents an award of restricted stock units covering Class B Common Stock, which vests in 48 equal monthly installments following the vesting commencement date of March 1, 2022. Includes 40,000 restricted stock units covering Class B Common Stock that were previously reported as Restricted Stock Units on the Form 4 filed by the reporting person on January 26, 2022. The reporting person intends to report such restricted stock units on a consolidated basis with his holdings of the underlying Class B Common Stock in future reports. Chief Financial Officer /s/ Karen Tepichin, Attorney-in-fact 2022-03-14